HOME >> BIOLOGY >> NEWS
Researchers identify enzyme essential for battle against bacteria in the intestine

St. Louis, Oct. 1, 1999 -- A paper in today's Science identifies an enzyme essential for the body's daily battle against bacteria in the intestine and possibly in other organs such as the lung and bladder. This work might one day help drug companies design more effective drugs to combat a myriad of diseases, including gingivitis, bladder infections and cystic fibrosis.

"This enzyme activates molecules called defensins, which people always thought were a key line of defense against bacteria. But no one has proven it until this paper," said senior author William C. Parks, Ph.D., associate professor of pediatrics and of cell biology and physiology at Washington University School of Medicine in St. Louis.

The enzyme, called matrilysin, belongs to a large family of enzymes called matrix metalloproteinases, or MMPs. Implicated in a surprising number of diseases, MMPs chew up proteins in the extracellular matrix, a supportive network surrounding cells.

When matrix-degrading metalloproteinases go overboard, they can cause disease. In osteoarthritis, for example, they are thought to break down cartilage in joints, making it painful and difficult for people to use their hands or walk. In cancer, tumor cells use the enzymes to tear down extracellular matrix, gaining passage into the bloodstream and spreading through the body.

MMPs also play important roles in healthy tissue. They often spur normal growth and healing, shaping embryos and remodeling skin in healing wounds.

The Science paper showed that matrilysin protects the epithelial lining of the intestine by regulating the activity of defensins. This might be a common role for this metalloproteinase in the many places where it is made.

Parks and lead author Carole L. Wilson, Ph.D., research assistant professor of pediatrics at Washington University School of Medicine, began studying matrilysin, which shows up in normal, uninjured
'"/>

Contact: Diane Duke Williams
duke@medicine.wustl.edu
314-286-0111
Washington University School of Medicine
1-Oct-1999


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... 2017 Sensory Inc ., a ... for consumer electronics, and i nnerCore ... cybersecurity solutions, today announced a global partnership that ... worldwide to bolster security of data sensitive mobile ... authentication platforms they offer, innerCore now offers its ...
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
(Date:1/11/2017)... N.J. , Jan. 11, 2017  Michael Johnson, co-founder of ... Venture Capital Group, Inc., has been named to the elite "Forbes ... 27,  was one of 600 people in 20 fields nationwide to ... percent of the 15,000 applicants were selected. ... He is currently a PhD candidate at ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... 19, 2017 , ... November Research Group, LLC, a global ... device manufacturers and regulators, is proud to announce the worldwide release of PRIMO ... to provide product vigilance departments with the flexibility and ease of use of ...
(Date:1/19/2017)... 2017 AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: ... aquaculture and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... the listing of its common shares on the NASDAQ ... "AquaBounty,s listing on NASDAQ represents an important ... to the U.S. markets as we advance plans for ...
(Date:1/19/2017)... Island, NY (PRWEB) , ... January 19, 2017 , ... ... at an exponential rate. The tremendous growth is accounted to two main factors. ... the table and the expanding network of vendors supplying FireflySci products all around the ...
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
Breaking Biology Technology:
Cached News: